These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1426890)

  • 1. Eradication of Helicobacter pylori reduces gastric and duodenal ulcer recurrence.
    Laine L
    Gastroenterology; 1992 Nov; 103(5):1695-6. PubMed ID: 1426890
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
    Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
    Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
    Graham DY; Lew GM; Klein PD; Evans DG; Evans DJ; Saeed ZA; Malaty HM
    Ann Intern Med; 1992 May; 116(9):705-8. PubMed ID: 1558340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
    Peura DA; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1137-9. PubMed ID: 8053422
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating peptic ulcer: an ongoing challenge.
    Cohen MH
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract]   [Full Text] [Related]  

  • 6. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
    al-Assi MT; Ramirez FC; Lew GM; Genta RM; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1203-5. PubMed ID: 8053435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of a tetracycline and Pepto-Bismol interaction in the management of Helicobacter pylori-induced peptic ulcer disease.
    Tkach CL; Ariano RE
    Ann Pharmacother; 1998 Mar; 32(3):387. PubMed ID: 9533072
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic.
    Patchin GM; Wieland KA; Carmichael JM
    Am J Health Syst Pharm; 1996 Sep; 53(17):2081-2. PubMed ID: 8991624
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].
    López-Brea M; Alarcón T
    Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Helicobacter pylori eradication on peptic ulcer disease complicated with outlet obstruction.
    Taskin V; Gurer I; Ozyilkan E; Sare M; Hilmioglu F
    Helicobacter; 2000 Mar; 5(1):38-40. PubMed ID: 10672050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and eradication of Helicobacter pylori in an isolated patient population.
    Myers D
    Mil Med; 1997 Jul; 162(7):507-9. PubMed ID: 9232984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HELIDAC therapy (bismuth subsalicylate/metronidazole/tetracycline hydrochloride).
    Claussen DW
    Gastroenterol Nurs; 1997; 20(5):188-9. PubMed ID: 9384064
    [No Abstract]   [Full Text] [Related]  

  • 15. [Helicobacter pylori: can it be a contributing factor in peptic ulcer in childhood?].
    Tovar-Calderón S; Casaubón-Garcín P; Ramírez-Mayans J; Cervantes R
    Bol Med Hosp Infant Mex; 1991 Oct; 48(10):743-8. PubMed ID: 1764199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of Helicobacter pylori infection and the recurrence of duodenal ulcers.
    Wang WM; Chen CY; Jan CM; Chen LT; Perng DS; Lin SR; Liu CS
    J Formos Med Assoc; 1993 Aug; 92(8):721-4. PubMed ID: 7904847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of tetracycline and metronidazole alone or with ranitidine on the healing of duodenal ulcer and eradication of Helicobacter pylori. A randomized controlled multicenter study. Tetra-Metro-Ran Study Group.
    Massarrat S; Ihm P; Koch HK
    Arzneimittelforschung; 1998 Jun; 48(6):686-90. PubMed ID: 9689428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies for Helicobacter pylori infection.
    Damianos AJ; McGarrity TJ
    Am Fam Physician; 1997 Jun; 55(8):2765-74, 2784-6. PubMed ID: 9191460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth.
    al-Assi MT; Genta RM; Karttunen TJ; Cole RA; Graham DY
    Am J Gastroenterol; 1995 Mar; 90(3):403-5. PubMed ID: 7872278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.